Von Hippel-Lindau Disease (VHL)
Overview
von Hippel-Lindau disease (VHL) is a rare genetic disorder that significantly increases the chance that you’ll have certain kinds of cancerous (malignant) tumors and noncancerous (benign) tumors and cysts. Healthcare providers may call this condition von Hippel-Lindau syndrome.
The condition happens if you inherit a specific genetic mutation (change). Research shows that by the time they’re 65 years old, 97% of people who carry this genetic mutation will develop tumors and other conditions that VHL causes. Surgery is the most common treatment for conditions that von Hippel-Landau disease may cause.
What cancers are associated with von Hippel-Landau disease?
Having this condition increases the chance you’ll have one or more of the following kinds of cancer:
Clear cell renal carcinoma (ccRCC): This is the most common form of renal cell carcinoma (kidney cancer). Experts estimate 25% to 60% of people with VHL disease have this cancer.
Pancreatic neuroendocrine tumors (pancreatic NETs): These are rare tumors that start in your pancreas’ endocrine cells. Between 9% and 17% of people with von Hipple-Landau disease develop pancreatic NETS.
Pheochromocytoma: This is a rare but treatable tumor that starts in your adrenal gland. Pheochromocytomas start as noncancerous tumors but can be cancerous. Between 10% and 20% of people with von Hippel-Lindau disease have pheochromocytomas.
Broad ligament cystadenomas: This condition affects 10% of females who have von Hippel-Lindau disease. A broad ligament cystadenoma is a tumor that starts near your fallopian tubes.
What noncancerous tumors are associated with VHL?
Hemangioblastomas are the most common noncancerous tumor that may happen if you have von Hippel-Landau disease. A hemangioblastoma is a noncancerous tumor that grows in the blood vessels in your brain, spinal cord or retina.
These tumors don’t spread from where they started (metastasize), but they can grow large enough to affect nearby tissue and cause serious health issues. Hemangioblastomas associated with von Hippel-Landau disease are:
Retinal hemangioblastoma: This is a type of eye tumor that can cause vision loss. Research shows that 60% of people with von Hippel-Lindau syndrome develop retinal hemangioblastoma.
Brain stem and cerebellar hemangioblastomas: These are brain tumors that may affect your balance and cause other issues. They may affect 13% to 72% of people with von Hippel Landau disease.
Spinal cord hemangioblastoma: Between 13% and 50% of people with VHL have this type of hemangioblastoma.
Having von Hippel-Landau disease may also increase your risk of developing the following noncancerous tumors and cysts:
Epididymal cystadenomas: These tumors affect males. They develop in your epididymis, the small tube-like structure near your testicles that stores sperm. Between 25% and 60% of males with von Hippel Lindau disease develop this type of tumor.
Endolymphatic sac tumors (ELST): This is a very rare tumor that may develop in your inner ear if you have VHL. Between 10% to 25% of people with von Hippel-Lindau disease have this condition.
Cysts: Cysts are growths filled with fluid. People with VHL may have cysts on or in their kidneys and pancreas.
Symptoms
This condition causes tumors throughout your body, which means you may have several different symptoms depending on where tumors develop and the tumors’ sizes. Symptoms may include:
Headaches.
Hearing loss or tinnitus.
High blood pressure.
Loss of balance.
Loss of muscle strength or coordination.
Vision issues.
Vomiting.
Causes
von Hippel-Lindau syndrome is an inherited disorder that may happen when one of your biological parents passes on an abnormal version of the VHL gene, a tumor suppressor gene that manages cell growth.
These genes make special proteins that put the brakes on cell growth that may cause cancer. When tumor suppressor genes mutate (change), it’s as if they switch from pressing on the brakes to hitting the gas pedal, suddenly putting cell growth into overdrive.
This disorder follows an autosomal dominant inheritance pattern. That means if you inherit an abnormal VHL gene from one of your biological parents, there’s a 50% chance that you’ll have von Hippel-Lindau disease. That being said, research shows up to 10% of people with VHL don’t have a family history of the disorder.
Diagnosis
Healthcare providers may suspect you have VHL if you have symptoms of one of the conditions that von Hippel-Lindau disease may cause, like a hemangioblastoma or clear cell renal carcinoma. But genetic testing is the only way to confirm that you have the condition. If anyone in your family has von Hippel-Lindau disease, ask your healthcare provider if genetic testing is right for you.
Treatment
Treatments vary depending on the type of tumor or cyst that VHL causes. Your healthcare provider will explain your treatment options. Common treatments are:
Surgery to remove tumors.
Chemotherapy.
Radiation therapy.
Targeted therapy, including peptide receptor radionuclide therapy (PPRT) and tyrosine kinase inhibitors (TKI).
Immunotherapy.
Hormone therapy.
Type of Doctor Department : A neurosurgeons (brain/spine), urologists (kidneys), ophthalmologists (retina), and endocrinologists (adrenal glands)
.jpg)
Comments
Post a Comment